Citations 1
P1101: PIRTOBRUTINIB, A HIGHLY SELECTIVE, NON-COVALENT (REVERSIBLE) BTK INHIBITOR IN PREVIOUSLY TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS FROM THE PHASE 1/2 BRUIN STUDY
Eyre, Toby A. , Wang, M. L., Shah, Nirav N. , Alencar, Alvaro J. , Gerson, James N. , Tan, Xuan , Fenske, Timothy S. , Wang, Y., Coombs, Catherine C. , Lewis, David , Gandhi, M., Chay, C., Palomba, M.Lia, Woyach, Jennifer A. , Pagel, John M. , Lamanna, Nicole , Sharman, Jeff P. , Andorsky, D. J., Cohen, Jonathon B. , Yin, Ming , Ujjani, Chaitra S. , Kherani, Jennifer , Nair, Binoj C., Tsai, Donald E. , Balbas, Minna, Mato, Anthony R. , Patel, Manish R. , Fakhri, Bita , Vandenberghe, Elisabeth , Jurczak, Wojciech , Lewis, Katharine L. , Wang, Yucai , Flinn, Ian W. , Gouill, Steven Le , Andorsky, David J., Barve, Minal , Ghia, Paolo , Yin, M., Zinzani, Pier Luigi , Koh, Youngil , Izutsu, Koji , Lech‐Marańda, Ewa , Tam, Constantine S. , Sundaram, Suchitra , Cheah, Chan Y.
HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 991-992
